Click for best price
Pharmaceutical CDMO Solution Market Size, Share 2024
The global Pharmaceutical CDMO Solution market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Active Pharmaceutical Ingredient (API) Manufacturing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Solution include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO Solution. This report contains market size and forecasts of Pharmaceutical CDMO Solution in global, including the following market information:
Global Pharmaceutical CDMO Solution Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Pharmaceutical CDMO Solution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Solution Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, by Type, 2023 (%)
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing
Secondary Packaging
Others
Global Pharmaceutical CDMO Solution Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, by Application, 2023 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Others
Global Pharmaceutical CDMO Solution Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Pharmaceutical CDMO Solution Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Solution revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Solution revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
Lonza Group
Catalent
Patheon (Thermo Fisher Scientific)
Siegfried AG
SGS Quay Pharmaceuticals
Curia
Societal CDMO
Aenova Group
Eurofins CDMO
Piramal Group
WuXi AppTec Group
Fareva
Strides Pharma Science
Famar Health Care Service
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical CDMO Solution, market overview.
Chapter 2: Global Pharmaceutical CDMO Solution market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical CDMO Solution company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical CDMO Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pharmaceutical CDMO Solution Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Solution Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Solution Overall Market Size
2.1 Global Pharmaceutical CDMO Solution Market Size: 2023 VS 2030
2.2 Global Pharmaceutical CDMO Solution Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Solution Players in Global Market
3.2 Top Global Pharmaceutical CDMO Solution Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Solution Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Solution Companies in Global Market, by Revenue in 2023
3.5 Global Companies Pharmaceutical CDMO Solution Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Solution Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Solution Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Solution Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceutical CDMO Solution Market Size Markets, 2023 & 2030
4.1.2 Active Pharmaceutical Ingredient (API) Manufacturing
4.1.3 Finished Dosage Formulation (FDF) Development and Manufacturing
4.1.4 Secondary Packaging
4.1.5 Others
4.2 By Type - Global Pharmaceutical CDMO Solution Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
4.2.2 By Type - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
4.2.3 By Type - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Solution Market Size, 2023 & 2030
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.1.5 Others
5.2 By Application - Global Pharmaceutical CDMO Solution Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
5.2.2 By Application - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
5.2.3 By Application - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Solution Market Size, 2023 & 2030
6.2 By Region - Global Pharmaceutical CDMO Solution Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Solution Revenue, 2019-2024
6.2.2 By Region - Global Pharmaceutical CDMO Solution Revenue, 2025-2030
6.2.3 By Region - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Solution Revenue, 2019-2030
6.3.2 US Pharmaceutical CDMO Solution Market Size, 2019-2030
6.3.3 Canada Pharmaceutical CDMO Solution Market Size, 2019-2030
6.3.4 Mexico Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Solution Revenue, 2019-2030
6.4.2 Germany Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.3 France Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.4 U.K. Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.5 Italy Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.6 Russia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.7 Nordic Countries Pharmaceutical CDMO Solution Market Size, 2019-2030
6.4.8 Benelux Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Solution Revenue, 2019-2030
6.5.2 China Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.3 Japan Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.4 South Korea Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.5 Southeast Asia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.5.6 India Pharmaceutical CDMO Solution Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Solution Revenue, 2019-2030
6.6.2 Brazil Pharmaceutical CDMO Solution Market Size, 2019-2030
6.6.3 Argentina Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Solution Revenue, 2019-2030
6.7.2 Turkey Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.3 Israel Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.4 Saudi Arabia Pharmaceutical CDMO Solution Market Size, 2019-2030
6.7.5 UAE Pharmaceutical CDMO Solution Market Size, 2019-2030
7 Pharmaceutical CDMO Solution Companies Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Company Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Solution Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.1.5 Recipharm AB Key News & Latest Developments
7.2 Lonza Group
7.2.1 Lonza Group Company Summary
7.2.2 Lonza Group Business Overview
7.2.3 Lonza Group Pharmaceutical CDMO Solution Major Product Offerings
7.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.2.5 Lonza Group Key News & Latest Developments
7.3 Catalent
7.3.1 Catalent Company Summary
7.3.2 Catalent Business Overview
7.3.3 Catalent Pharmaceutical CDMO Solution Major Product Offerings
7.3.4 Catalent Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.3.5 Catalent Key News & Latest Developments
7.4 Patheon (Thermo Fisher Scientific)
7.4.1 Patheon (Thermo Fisher Scientific) Company Summary
7.4.2 Patheon (Thermo Fisher Scientific) Business Overview
7.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Major Product Offerings
7.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.4.5 Patheon (Thermo Fisher Scientific) Key News & Latest Developments
7.5 Siegfried AG
7.5.1 Siegfried AG Company Summary
7.5.2 Siegfried AG Business Overview
7.5.3 Siegfried AG Pharmaceutical CDMO Solution Major Product Offerings
7.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.5.5 Siegfried AG Key News & Latest Developments
7.6 SGS Quay Pharmaceuticals
7.6.1 SGS Quay Pharmaceuticals Company Summary
7.6.2 SGS Quay Pharmaceuticals Business Overview
7.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Major Product Offerings
7.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.6.5 SGS Quay Pharmaceuticals Key News & Latest Developments
7.7 Curia
7.7.1 Curia Company Summary
7.7.2 Curia Business Overview
7.7.3 Curia Pharmaceutical CDMO Solution Major Product Offerings
7.7.4 Curia Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.7.5 Curia Key News & Latest Developments
7.8 Societal CDMO
7.8.1 Societal CDMO Company Summary
7.8.2 Societal CDMO Business Overview
7.8.3 Societal CDMO Pharmaceutical CDMO Solution Major Product Offerings
7.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.8.5 Societal CDMO Key News & Latest Developments
7.9 Aenova Group
7.9.1 Aenova Group Company Summary
7.9.2 Aenova Group Business Overview
7.9.3 Aenova Group Pharmaceutical CDMO Solution Major Product Offerings
7.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.9.5 Aenova Group Key News & Latest Developments
7.10 Eurofins CDMO
7.10.1 Eurofins CDMO Company Summary
7.10.2 Eurofins CDMO Business Overview
7.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Major Product Offerings
7.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.10.5 Eurofins CDMO Key News & Latest Developments
7.11 Piramal Group
7.11.1 Piramal Group Company Summary
7.11.2 Piramal Group Business Overview
7.11.3 Piramal Group Pharmaceutical CDMO Solution Major Product Offerings
7.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.11.5 Piramal Group Key News & Latest Developments
7.12 WuXi AppTec Group
7.12.1 WuXi AppTec Group Company Summary
7.12.2 WuXi AppTec Group Business Overview
7.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Major Product Offerings
7.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.12.5 WuXi AppTec Group Key News & Latest Developments
7.13 Fareva
7.13.1 Fareva Company Summary
7.13.2 Fareva Business Overview
7.13.3 Fareva Pharmaceutical CDMO Solution Major Product Offerings
7.13.4 Fareva Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.13.5 Fareva Key News & Latest Developments
7.14 Strides Pharma Science
7.14.1 Strides Pharma Science Company Summary
7.14.2 Strides Pharma Science Business Overview
7.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Major Product Offerings
7.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.14.5 Strides Pharma Science Key News & Latest Developments
7.15 Famar Health Care Service
7.15.1 Famar Health Care Service Company Summary
7.15.2 Famar Health Care Service Business Overview
7.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Major Product Offerings
7.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue in Global Market (2019-2024)
7.15.5 Famar Health Care Service Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmaceutical CDMO Solution Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical CDMO Solution Market Drivers in Global Market
Table 3. Pharmaceutical CDMO Solution Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical CDMO Solution in Global Market
Table 5. Top Pharmaceutical CDMO Solution Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Pharmaceutical CDMO Solution Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Pharmaceutical CDMO Solution Revenue Share by Companies, 2019-2024
Table 8. Global Companies Pharmaceutical CDMO Solution Product Type
Table 9. List of Global Tier 1 Pharmaceutical CDMO Solution Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Solution Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Pharmaceutical CDMO Solution Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Pharmaceutical CDMO Solution Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Pharmaceutical CDMO Solution Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Pharmaceutical CDMO Solution Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Pharmaceutical CDMO Solution Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Pharmaceutical CDMO Solution Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2025-2030
Table 30. Recipharm AB Company Summary
Table 31. Recipharm AB Pharmaceutical CDMO Solution Product Offerings
Table 32. Recipharm AB Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 33. Recipharm AB Key News & Latest Developments
Table 34. Lonza Group Company Summary
Table 35. Lonza Group Pharmaceutical CDMO Solution Product Offerings
Table 36. Lonza Group Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 37. Lonza Group Key News & Latest Developments
Table 38. Catalent Company Summary
Table 39. Catalent Pharmaceutical CDMO Solution Product Offerings
Table 40. Catalent Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 41. Catalent Key News & Latest Developments
Table 42. Patheon (Thermo Fisher Scientific) Company Summary
Table 43. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product Offerings
Table 44. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 45. Patheon (Thermo Fisher Scientific) Key News & Latest Developments
Table 46. Siegfried AG Company Summary
Table 47. Siegfried AG Pharmaceutical CDMO Solution Product Offerings
Table 48. Siegfried AG Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 49. Siegfried AG Key News & Latest Developments
Table 50. SGS Quay Pharmaceuticals Company Summary
Table 51. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product Offerings
Table 52. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 53. SGS Quay Pharmaceuticals Key News & Latest Developments
Table 54. Curia Company Summary
Table 55. Curia Pharmaceutical CDMO Solution Product Offerings
Table 56. Curia Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 57. Curia Key News & Latest Developments
Table 58. Societal CDMO Company Summary
Table 59. Societal CDMO Pharmaceutical CDMO Solution Product Offerings
Table 60. Societal CDMO Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 61. Societal CDMO Key News & Latest Developments
Table 62. Aenova Group Company Summary
Table 63. Aenova Group Pharmaceutical CDMO Solution Product Offerings
Table 64. Aenova Group Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 65. Aenova Group Key News & Latest Developments
Table 66. Eurofins CDMO Company Summary
Table 67. Eurofins CDMO Pharmaceutical CDMO Solution Product Offerings
Table 68. Eurofins CDMO Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 69. Eurofins CDMO Key News & Latest Developments
Table 70. Piramal Group Company Summary
Table 71. Piramal Group Pharmaceutical CDMO Solution Product Offerings
Table 72. Piramal Group Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 73. Piramal Group Key News & Latest Developments
Table 74. WuXi AppTec Group Company Summary
Table 75. WuXi AppTec Group Pharmaceutical CDMO Solution Product Offerings
Table 76. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 77. WuXi AppTec Group Key News & Latest Developments
Table 78. Fareva Company Summary
Table 79. Fareva Pharmaceutical CDMO Solution Product Offerings
Table 80. Fareva Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 81. Fareva Key News & Latest Developments
Table 82. Strides Pharma Science Company Summary
Table 83. Strides Pharma Science Pharmaceutical CDMO Solution Product Offerings
Table 84. Strides Pharma Science Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 85. Strides Pharma Science Key News & Latest Developments
Table 86. Famar Health Care Service Company Summary
Table 87. Famar Health Care Service Pharmaceutical CDMO Solution Product Offerings
Table 88. Famar Health Care Service Pharmaceutical CDMO Solution Revenue (US$, Mn) & (2019-2024)
Table 89. Famar Health Care Service Key News & Latest Developments
List of Figures
Figure 1. Pharmaceutical CDMO Solution Segment by Type in 2023
Figure 2. Pharmaceutical CDMO Solution Segment by Application in 2023
Figure 3. Global Pharmaceutical CDMO Solution Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical CDMO Solution Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pharmaceutical CDMO Solution Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical CDMO Solution Revenue in 2023
Figure 8. By Type - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 9. By Application - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 10. By Type - Global Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 12. By Application - Global Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 14. By Region - Global Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 15. By Country - North America Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 16. US Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 20. Germany Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 21. France Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 28. China Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 32. India Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 34. Brazil Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Pharmaceutical CDMO Solution Revenue Market Share, 2019-2030
Figure 37. Turkey Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Pharmaceutical CDMO Solution Revenue, (US$, Mn), 2019-2030
Figure 41. Recipharm AB Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Lonza Group Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Catalent Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Siegfried AG Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Curia Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Societal CDMO Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Aenova Group Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Eurofins CDMO Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Piramal Group Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Fareva Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Strides Pharma Science Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Famar Health Care Service Pharmaceutical CDMO Solution Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
